ArticleNature communications2021
Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignancies.
Guy Biber et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it